IC
SHPH icon

Ikarian Capital’s Shuttle Pharmaceuticals SHPH Stock Holding History

Ikarian Capital’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,899
Closed -$46.8K – 189
2026
Q1 		$46.8K Hold
6,899
– – ﹤0.01% 155
2025
Q4 		$124K Buy
+6,899
New +$176K 0.01% 159

Other funds holding SHPH

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Ikarian Capital's SHPH Position: Q2 2026 in Review

Ikarian Capital sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2026, closing a stake of 6,899 shares — an estimated $46.8K sold.

Ikarian Capital first reported a position in SHPH in Q4 2025 and held it in 2 quarters. The position peaked at $124K in Q4 2025. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

  • Ikarian Capital reported no remaining Shuttle Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Ikarian Capital sold 6,899 Shuttle Pharmaceuticals shares in Q2 2026, an estimated $46.8K.
  • Ikarian Capital first reported a position in Shuttle Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Ikarian Capital's Shuttle Pharmaceuticals position peaked at $124K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.